理解组织背景对肿瘤异质性的影响。
Understanding tissue context influences on intratumour heterogeneity.
机构信息
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts 02215, USA.
Center for Bioengineering and Tissue Regeneration and Departments of Surgery, Anatomy, Bioengineering and Therapeutics, Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, and Helen Diller Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143, USA.
出版信息
Nat Cell Biol. 2014 Apr;16(4):301-2. doi: 10.1038/ncb2942.
Abstract
Although human cancers exhibit intratumour heterogeneity, the influence of the tumour environment on this property is unclear. Single basal-like mammary epithelial cells are now shown to engage a dynamic TGFBR3-JUND signalling circuit in an extracellular-matrix-dependent manner. Cell transition between the distinct gene expression states underlying this circuit alters their properties and may modulate their propensity to malignancy.
摘要
尽管人类癌症表现出肿瘤内异质性，但肿瘤微环境对其的影响尚不清楚。现在发现，单个基底样乳腺上皮细胞以细胞外基质依赖的方式激活一个动态的 TGFBR3-JUND 信号通路。该通路所依赖的不同基因表达状态下的细胞转换改变了它们的特性，并可能调节它们的恶性倾向。
相似文献
1
Understanding tissue context influences on intratumour heterogeneity.
Nat Cell Biol. 2014 Apr;16(4):301-2. doi: 10.1038/ncb2942.
2
A time- and matrix-dependent TGFBR3-JUND-KRT5 regulatory circuit in single breast epithelial cells and basal-like premalignancies.
Nat Cell Biol. 2014 Apr;16(4):345-56. doi: 10.1038/ncb2930. Epub 2014 Mar 23.
3
Non-genetic heterogeneity caused by differential single-cell adhesion.
Cell Cycle. 2014;13(14):2149-50. doi: 10.4161/cc.29660. Epub 2014 Jun 23.
4
[Papillary lesions of the breast].
Zhonghua Bing Li Xue Za Zhi. 2013 Nov;42(11):721-6.
5
Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Jpn J Clin Oncol. 2012 May;42(5):375-86. doi: 10.1093/jjco/hys034. Epub 2012 Mar 26.
6
Papillary Lesions of the Breast: A Practical Approach to Diagnosis.
Arch Pathol Lab Med. 2016 Oct;140(10):1052-9. doi: 10.5858/arpa.2016-0219-RA.
7
[Clinicopathologic and immunohistochemical study of 187 cases of intraductal papillary neoplasm of breast].
Zhonghua Bing Li Xue Za Zhi. 2011 Nov;40(11):726-31.
8
[Value of CK5/6, CK14, ER and PR detection in differential diagnosis of intraductal proliferative lesions of the breast].
Zhonghua Zhong Liu Za Zhi. 2015 Oct;37(10):749-52.
9
[The breast stem cell (CK5/6(+)) concept and its relation to the diagnosis of benign and malignant ductal epithelial hyperplasia].
Zhonghua Bing Li Xue Za Zhi. 2013 Feb;42(2):73-7. doi: 10.3760/cma.j.issn.0529-5807.2013.02.001.
10
The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer.
BMC Cancer. 2016 Aug 23;16(1):671. doi: 10.1186/s12885-016-2697-z.
引用本文的文献
1
Ordered micropattern arrays fabricated by lung-derived dECM hydrogels for chemotherapeutic drug screening.
Mater Today Bio. 2022 May 5;15:100274. doi: 10.1016/j.mtbio.2022.100274. eCollection 2022 Jun.
2
Anticancer and chemosensitization effects of cannabidiol in 2D and 3D cultures of TNBC: involvement of GADD45α, integrin-α5, -β5, -β1, and autophagy.
Drug Deliv Transl Res. 2022 Nov;12(11):2762-2777. doi: 10.1007/s13346-022-01137-2. Epub 2022 Feb 25.
3
Polysaccharide hydrogel based 3D printed tumor models for chemotherapeutic drug screening.
Sci Rep. 2021 Jan 11;11(1):372. doi: 10.1038/s41598-020-79325-8.
4
Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicine.
JHEP Rep. 2020 Jan 16;2(2):100068. doi: 10.1016/j.jhepr.2020.100068. eCollection 2020 Apr.
5
Steps in Mechanotransduction Pathways that Control Cell Morphology.
Annu Rev Physiol. 2019 Feb 10;81:585-605. doi: 10.1146/annurev-physiol-021317-121245. Epub 2018 Nov 7.
6
From Chemotherapy to Combined Targeted Therapeutics: and Models to Decipher Intra-tumor Heterogeneity.
Front Pharmacol. 2018 Feb 14;9:77. doi: 10.3389/fphar.2018.00077. eCollection 2018.
7
Micropharmacology: An In Silico Approach for Assessing Drug Efficacy Within a Tumor Tissue.
Bull Math Biol. 2019 Sep;81(9):3623-3641. doi: 10.1007/s11538-018-0402-x. Epub 2018 Feb 8.
8
Human colorectal cancer progression correlates with LOX-induced ECM stiffening.
Int J Biol Sci. 2017 Nov 1;13(11):1450-1457. doi: 10.7150/ijbs.21230. eCollection 2017.
9
Cancer stem cells and early stage basal-like breast cancer.
World J Obstet Gynecol. 2016 May 10;5(2):150-161. doi: 10.5317/WJOG.v5.i2.150.
10
The characteristics of Ishikawa endometrial cancer cells are modified by substrate topography with cell-like features and the polymer surface.
Int J Nanomedicine. 2015 Aug 3;10:4883-95. doi: 10.2147/IJN.S86336. eCollection 2015.
本文引用的文献
1
A time- and matrix-dependent TGFBR3-JUND-KRT5 regulatory circuit in single breast epithelial cells and basal-like premalignancies.
Nat Cell Biol. 2014 Apr;16(4):345-56. doi: 10.1038/ncb2930. Epub 2014 Mar 23.
2
Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity.
Cell Rep. 2014 Feb 13;6(3):514-27. doi: 10.1016/j.celrep.2013.12.041. Epub 2014 Jan 23.
3
Intratumor heterogeneity: seeing the wood for the trees.
Sci Transl Med. 2012 Mar 28;4(127):127ps10. doi: 10.1126/scitranslmed.3003854.
4
Clonal evolution in cancer.
Nature. 2012 Jan 18;481(7381):306-13. doi: 10.1038/nature10762.
5
Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs.
Nat Med. 2011 Jun 26;17(7):867-74. doi: 10.1038/nm.2379.
6
Tumor-host interactions: a far-reaching relationship.
J Clin Oncol. 2010 Sep 10;28(26):4022-8. doi: 10.1200/JCO.2010.28.4257. Epub 2010 Jul 19.
7
Genetic clonal diversity predicts progression to esophageal adenocarcinoma.
Nat Genet. 2006 Apr;38(4):468-73. doi: 10.1038/ng1768. Epub 2006 Mar 26.
8
Stromal fibroblasts in cancer initiation and progression.
Nature. 2004 Nov 18;432(7015):332-7. doi: 10.1038/nature03096.
9
Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome.
Am J Pathol. 2002 Dec;161(6):1991-6. doi: 10.1016/S0002-9440(10)64476-8.
10
Putting tumours in context.
Nat Rev Cancer. 2001 Oct;1(1):46-54. doi: 10.1038/35094059.
Zotero 插件